We are live on
!
Find out more
TM
Tiger Management Portfolio holdings
AUM
$22.8M
1-Year Est. Return
0.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+0.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$553M
AUM Growth
+$44.1M
(+8.7%)
Cap. Flow
+$10.7M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
59.15%
Holding
48
New
6
Increased
15
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$19.6M |
| 2 |
JD.com
JD
|
+$13.6M |
| 3 |
Royal Caribbean
RCL
|
+$7.45M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.69M |
| 5 |
JPMorgan Chase
JPM
|
+$5.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$23.1M |
| 2 |
Booking.com
BKNG
|
+$21.6M |
| 3 |
Nike
NKE
|
+$20.1M |
| 4 |
CELG
Celgene Corp
CELG
|
+$8.68M |
| 5 |
Alibaba
BABA
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.24% |
| 2 | Financials | 19.23% |
| 3 | Consumer Discretionary | 18.21% |
| 4 | Technology | 17.89% |
| 5 | Communication Services | 14.06% |
Similar funds
CMG
SRCM
A
KLM
OCM
LC
PFG
ICP
Tiger Management's Q3 2017 Portfolio in Review
As of Q3 2017, Tiger Management held 48 positions worth $553M, up 8.7% from $509M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Tiger Management's Q3 2017 filing shows 6 new, 15 increased, 6 reduced and 3 closed positions. Its largest new stake was Elevance Health: 103,000 shares worth $19.6M. The largest sale was Teva Pharmaceuticals, an estimated $23.1M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Tiger Management's largest Q3 2017 buy was Elevance Health: 103,000 shares worth $19.6M.
- Tiger Management added most to Royal Caribbean in Q3 2017, an estimated $7.45M increase.
- Tiger Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $8.68M.
- Tiger Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $23.1M.
- Tiger Management's ten largest holdings make up 59% of its $553M portfolio in Q3 2017.
- Tiger Management opened 6 new positions and closed 3 in Q3 2017.
- Tiger Management's portfolio value rose 8.7% quarter-over-quarter to $553M.
Based on Tiger Management's 13F filing for Q3 2017, filed 14 Nov 2017.